Harrow, Inc. continues to execute on its branded ophthalmic portfolio, with Vevye and Iheezo outperforming expectations. Read ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Ayurveda thrives in India as govt support and patient awareness align: Ameve Sharma: Nandita Vijayasimha, Bengaluru Friday, January 23, 2026, 08:00 Hrs [IST] Ayurveda is experienc ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

If those pieces fall into place, 2026 can be the year the sector surprises people, because expectations are already low and ...

Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...

Dollar plunges as Goldilocks PCE and GDP data trigger risk-on flows. DXY breaks bearish, targeting 97.749 as money rotates ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

Today’s price action in Bitcoin and Ethereum confirms something important: both markets have rolled over, and momentum is shifting back to the downside.

Even though it’s the most trusted profession, doctors may not have all the answers all the time — rushed appointments, long ...

The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational Pathway: ISSCR Best ...

Tilray shares are trading higher in pre-market activity today following a significant strategic announcement concerning its European operations. The company is launching a concerted effort to ...